Herceptin Trastuzumab 660mg Breast Cancer Sourcing in Rio de Janeiro and São Paulo Brazil ANVISA 2026
Author: Dra. Camila Ferreira
On September 26, 2026, Brazilian breast cancer societies in Rio de Janeiro and São Paulo updated patient access pathways for subcutaneous HER2-targeted biologics. Sourcing authentic Herceptin (Trastuzumab) 660mg Injection through ANVISA-compliant channels helps HER2-positive patients maintain treatment when local pharmacy stock is limited.
At Onco Medicine, we ship batch-verified trastuzumab with validated 2–8°C packaging, complete ANVISA documentation, and Receita Federal customs support to all Brazilian states.
HER2 Therapy Access in Brazil
- 660mg Subcutaneous Dose: Fixed-dose injection over 2–5 minutes, reducing infusion chair time versus IV formulations.
- ANVISA Import Rules: Valid CRM oncologist prescription, personal-use declaration, and full customs documentation required.
- Biological Stability: Trastuzumab must stay at 2–8°C; shipments include gel-pack validated insulation and temperature data loggers.
- Nationwide Delivery: Priority air freight reaches Rio, São Paulo, Brasília, and regional cities within 8–14 business days.
Visit Brazil cancer medicine delivery or email support@onco-medicine.com.
